-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, IuxnrEuaWR4QjV4TYNeVn5pUB31CxfNz5cOKfU/KfTdA7b8sCOTI6mgviPPxFYYm R03VIoVznkVUBuuS+WS1iQ== 0001181431-10-052407.txt : 20101028 0001181431-10-052407.hdr.sgml : 20101028 20101028193116 ACCESSION NUMBER: 0001181431-10-052407 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20101026 FILED AS OF DATE: 20101028 DATE AS OF CHANGE: 20101028 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MEDIVATION, INC. CENTRAL INDEX KEY: 0001011835 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133863260 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 201 SPEAR STREET, 3RD FLOOR CITY: SAN FRANCISCO STATE: CA ZIP: 94105 BUSINESS PHONE: 415-543-3470 MAIL ADDRESS: STREET 1: 201 SPEAR STREET, 3RD FLOOR CITY: SAN FRANCISCO STATE: CA ZIP: 94105 FORMER COMPANY: FORMER CONFORMED NAME: ORION ACQUISITION CORP II DATE OF NAME CHANGE: 19960408 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: QVT Associates GP LLC CENTRAL INDEX KEY: 0001290166 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-32836 FILM NUMBER: 101149436 BUSINESS ADDRESS: STREET 1: 1177 AVENUE OF THE AMERICAS STREET 2: 9TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10036 BUSINESS PHONE: 212-705-8800 MAIL ADDRESS: STREET 1: 1177 AVENUE OF THE AMERICAS STREET 2: 9TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10036 4 1 rrd289459.xml FORM 4 X0303 4 2010-10-26 0 0001011835 MEDIVATION, INC. MDVN 0001290166 QVT Associates GP LLC 1177 AVENUE OF THE AMERICAS 9TH FLOOR NEW YORK NY 10036 0 0 1 0 Common Stock, $0.01 par value 2010-10-26 4 P 0 40914 11.44 A 3951030 I Through QVT Fund LP and Quintessence Fund L.P. Common Stock, $0.01 par value 2010-10-27 4 P 0 14901 11.42 A 3965931 I Through QVT Fund LP and Quintessence Fund L.P. On October 26, 2010, QVT Fund LP purchased 36,966 shares of Common Stock and Quintessence Fund L.P. purchased 3,948 shares of Common Stock. On October 27, 2010, QVT Fund LP purchased 13,463 shares of Common Stock and Quintessence Fund L.P. purchased 1,438 shares of Common Stock. As a result, QVT Fund LP directly beneficially owns 1,664,015 shares of Common Stock and Quintessence Fund L.P. directly beneficially owns 437,150 shares of Common Stock. QVT Associates GP LLC, as General Partner of QVT Fund LP and Quintessence Fund L.P., may be deemed to beneficially own the aggregate number of shares of Common Stock owned by QVT Fund LP and Quintessence Fund L.P., as well as the shares held by all of the other entities to which it serves as General Partner, and accordingly, QVT Associates GP LLC may be deemed to be the indirect beneficial owner of an aggregate amount of 3,965,931 shares of Common Stock. The reporting person disclaims beneficial ownership of the reported securities except to the ext ent of its pecuniary interest therein. /s/ Tracy Fu, Managing Member 2010-10-28 -----END PRIVACY-ENHANCED MESSAGE-----